The aim of this review is to outline the role of major CH driver mutations, review the influence of other factors in CH and discuss the transformation to hematologic neoplasms, with a focus on myelodysplastic syndromes (MDS), myeloproliferative neoplasms (MPNs), and acute myeloid leukemia (AML). This evidence concerns the gene C4B and acute myeloid leukemia.